Effect of Levonorgestrel Intrauterine System on Hemoglobin Level

N/ANot Yet RecruitingNCT06935968

Assiut University100 enrolled

Overview

To study the effect of LNG-IUS on improving iron status in reproductive-aged women presenting for contraception.

Women come to family planning clinic to insert levonorgestrel intrautrine system and take a blood sample from her to analyse hemoglobin level

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

100

Conditions

Hemoglobin; Deficiency

Interventions

Levonorgestrel intrautrine systemDEVICE

Insertion of levonorgestrel intrautrine system and take a blood sample from the women to analyse it

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. The study will include married women attending the outpatient clinics of the forementioned health facilities for contraception counseling 2. Age between 18 and 45 years 3. Women who choose LNG\_IUS for contraception 4. Any parity including nulliparous Exclusion Criteria: * 1.Women with any inherited hemoglobinopathy (thalassemia, sickle cell anemia) or acquired hemolytic anemia 2.Women with sever iron deficiency anemia requiring immediate treatment 3.Women with any contraindication to Mirena insertion (pelvic inflammatory disease, cervical or vaginal infection, cervical cancer) 4. Any uterine abnormality making LNG\_IUS insertion difficult (septate uterus or fibroid distorting the cavity) 5. Women within 6 months of delivery

Outcomes

Primary Outcomes

Change of blood haemoglobin level from time of insertion to 6 months after insertion

To know the effect of LNG-IUDs on hemoglobin level after insertion

Time frame: 6 months

Secondary Outcomes

Change of serum ferritin level from time of insertion to 6 months after insertionPrevalence of iron deficiency and iron deficiency anemia in women requiring contraception in our community

To know the effect of LNG-IUDs in serum ferritin

Time frame: 6 months

Central Contacts

Mariam Melad

CONTACT

01020214925 mariomamelad8@gmail.com

Essam eldeen Rashad

CONTACT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.